Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$9.16M Buy
36,406
+2,485
+7% +$535K 0.95% 30
2026
Q1
$7.38M Buy
33,921
+143
+0.4% +$31.7K 0.85% 36
2025
Q4
$7.72M Sell
33,778
-513
-1% -$117K 0.85% 31
2025
Q3
$7.94M Buy
34,291
+25
+0.1% +$5.09K 0.9% 29
2025
Q2
$6.36M Buy
34,266
+1,005
+3% +$187K 0.77% 36
2025
Q1
$6.97M Buy
33,261
+820
+3% +$159K 0.9% 31
2024
Q4
$5.76M Sell
32,441
-106
-0.3% -$19.5K 0.74% 41
2024
Q3
$6.43M Sell
32,547
-711
-2% -$133K 0.84% 37
2024
Q2
$5.7M Buy
33,258
+735
+2% +$122K 0.77% 39
2024
Q1
$5.92M Buy
32,523
+545
+2% +$93.9K 0.82% 40
2023
Q4
$4.96M Sell
31,978
-319
-1% -$46.5K 0.73% 40
2023
Q3
$4.81M Buy
32,297
+13
+0% +$1.91K 0.78% 39
2023
Q2
$4.35M Sell
32,284
-55
-0.2% -$8.06K 0.7% 40
2023
Q1
$5.15M Buy
32,339
+668
+2% +$102K 0.88% 36
2022
Q4
$5.12M Buy
31,671
+148
+0.5% +$22.7K 0.93% 35
2022
Q3
$4.23M Buy
31,523
+1,335
+4% +$192K 0.83% 36
2022
Q2
$4.62M Buy
30,188
+1,893
+7% +$289K 0.88% 36
2022
Q1
$4.59M Sell
28,295
-3,005
-10% -$437K 0.73% 41
2021
Q4
$4.24M Buy
31,300
+3,147
+11% +$372K 0.61% 47
2021
Q3
$3.04M Buy
28,153
+400
+1% +$45.7K 0.48% 53
2021
Q2
$3.13M Sell
27,753
-206
-0.7% -$23.2K 0.49% 52
2021
Q1
$3.03M Buy
27,959
+268
+1% +$28.7K 0.51% 52
2020
Q4
$2.97M Buy
27,691
+530
+2% +$50.9K 0.53% 49
2020
Q3
$2.38M Hold
27,161
0.48% 54
2020
Q2
$2.67M Buy
27,161
+794
+3% +$69.9K 0.59% 49
2020
Q1
$2.01M Sell
26,367
-167
-0.6% -$14.2K 0.54% 56
2019
Q4
$2.35M Buy
26,534
+1,896
+8% +$157K 0.5% 57
2019
Q3
$1.87M Buy
24,638
+2,001
+9% +$137K 0.43% 68
2019
Q2
$1.65M Sell
22,637
-96
-0.4% -$7.55K 0.38% 70
2019
Q1
$1.83M Buy
22,733
+1,126
+5% +$92.1K 0.45% 71
2018
Q4
$1.99M Buy
21,607
+1,829
+9% +$161K 0.56% 61
2018
Q3
$1.87M Buy
19,778
+225
+1% +$21.3K 0.44% 71
2018
Q2
$1.81M Buy
19,553
+97
+0.5% +$9.47K 0.46% 69
2018
Q1
$1.84M Buy
19,456
+220
+1% +$24.2K 0.47% 66
2017
Q4
$1.86M Buy
19,236
+2,998
+18% +$283K 0.47% 65
2017
Q3
$1.44M Sell
16,238
-275
-2% -$20.9K 0.39% 73
2017
Q2
$1.2M Sell
16,513
-74
-0.4% -$4.97K 0.32% 77
2017
Q1
$1.08M Buy
16,587
+60
+0.4% +$3.77K 0.3% 82
2016
Q4
$1.03M Buy
16,527
+2,500
+18% +$153K 0.3% 81
2016
Q3
$885K Hold
14,027
0.27% 88
2016
Q2
$868K Buy
14,027
+571
+4% +$34.8K 0.26% 88
2016
Q1
$769K Buy
13,456
+153
+1% +$8.53K 0.24% 91
2015
Q4
$788K Sell
13,303
-1,899
-12% -$109K 0.25% 90
2015
Q3
$827K Sell
15,202
-25
-0.2% -$1.63K 0.28% 83
2015
Q2
$1.02M Buy
15,227
+25
+0.2% +$1.63K 0.33% 75
2015
Q1
$890K Buy
15,202
+443
+3% +$26.8K 0.29% 81
2014
Q4
$966K Buy
14,759
+1
+0% +$63 0.32% 75
2014
Q3
$852K Sell
14,758
-8,370
-36% -$465K 0.29% 78
2014
Q2
$1.3M Sell
23,128
-859
-4% -$45.1K 0.43% 62
2014
Q1
$1.23M Sell
23,987
-49
-0.2% -$2.48K 0.44% 65
2013
Q4
$1.27M Buy
24,036
+47
+0.2% +$2.31K 0.44% 66
2013
Q3
$1.07M Hold
23,989
0.41% 67
2013
Q2
$992K Buy
+23,989
New +$1.05M 0.41% 64

Other funds holding ABBV

J.W. Burns & Co's ABBV Position: Q2 2026 in Review

J.W. Burns & Co increased its AbbVie (ABBV) stake by 7.3% in Q2 2026, buying an estimated $535K and bringing the position to 36,406 shares worth $9.16M. The position accounts for 0.95% of the portfolio, ranked #30.

J.W. Burns & Co first reported a position in ABBV in Q2 2013 and has held it in 53 quarters since. 4,193 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

  • J.W. Burns & Co held 36,406 shares of AbbVie worth $9.16M as of Q2 2026.
  • J.W. Burns & Co bought 2,485 AbbVie shares in Q2 2026, an estimated $535K.
  • AbbVie made up 0.95% of J.W. Burns & Co's portfolio in Q2 2026, its #30 holding.
  • J.W. Burns & Co first reported a position in AbbVie in Q2 2013 and has held it in 53 quarters since.
  • 4,193 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on J.W. Burns & Co's 13F filing for Q2 2026, filed 15 Jul 2026.